ROSSI, MAURA
 Distribuzione geografica
Continente #
NA - Nord America 1157
EU - Europa 861
AS - Asia 468
AF - Africa 78
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2568
Nazione #
US - Stati Uniti d'America 1147
GB - Regno Unito 360
CN - Cina 201
VN - Vietnam 172
SE - Svezia 148
IT - Italia 87
UA - Ucraina 71
IN - India 65
DE - Germania 57
RU - Federazione Russa 50
TG - Togo 45
FR - Francia 43
ZA - Sudafrica 31
EE - Estonia 24
IR - Iran 16
CA - Canada 10
BE - Belgio 4
GR - Grecia 4
TR - Turchia 4
BR - Brasile 3
CH - Svizzera 3
NL - Olanda 3
PH - Filippine 3
FI - Finlandia 2
LB - Libano 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
ES - Italia 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
LU - Lussemburgo 1
Totale 2568
Città #
Southend 343
Fairfield 193
Dong Ket 112
Houston 100
Seattle 90
Princeton 89
Chandler 83
Wilmington 79
Woodbridge 78
Ann Arbor 69
Ashburn 69
Cambridge 58
Lomé 45
Nanjing 39
Westminster 35
Padova 31
Bologna 22
Berlin 20
Saint Petersburg 19
Hebei 18
Jacksonville 18
Shenyang 18
Jinan 15
Medford 15
Beijing 14
Nanchang 13
Jiaxing 12
Changsha 11
San Diego 10
Redwood City 9
Toronto 9
Taizhou 8
Falls Church 7
Hangzhou 7
Tianjin 7
Ardabil 6
Redmond 6
Zhengzhou 6
Dearborn 5
Fremont 5
Kuban 5
Monmouth Junction 5
Ningbo 5
San Venanzo 5
Brussels 4
Guangzhou 4
Kunming 4
Leawood 4
Norwalk 4
Zanjan 4
Den Haag 3
Haikou 3
Istanbul 3
Milan 3
Phoenix 3
Sacramento 3
San Mateo 3
São Paulo 3
Bratislava 2
Des Moines 2
Frankfurt Am Main 2
Hefei 2
Helsinki 2
Lanzhou 2
Mahé 2
Rome 2
San Francisco 2
Shanghai 2
Taiyuan 2
Verona 2
Andover 1
Athens 1
Bhavnagar 1
Castenedolo 1
Changchun 1
Chicago 1
Dublin 1
Frankfurt am Main 1
Fusignano 1
Fuzhou 1
Kiev 1
Lausanne 1
Markham 1
Mumbai 1
Orange 1
Plauen 1
Pozza 1
Provo 1
Ryazan 1
Saint Louis 1
Samarate 1
Silverton 1
Tokyo 1
Torino 1
Venezia 1
Yerevan 1
Totale 1911
Nome #
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 138
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 116
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 114
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 102
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 102
BCL10 down-regulation in peripheral T-cell lymphomas. 102
null 97
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 96
Pathobiology of hodgkin lymphoma. 94
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 93
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 89
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 88
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 87
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 87
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 83
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas 80
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 78
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 75
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 74
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus 69
Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas. 69
Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues. 68
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 67
Peripheral T-cell lymphomas not otherwise specified correspond to distinct mature T-cell populations basing on the global gene expression profile. 65
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 64
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 62
P27 regulation in peripheral T-cell lymphoma not otherwise specified 55
Identification and validation of PDGFRa as therapeutic target for PTCL-NOS. 54
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 53
PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. 51
Gene expression profiling of peripheral T-cell lymphoma: From bench to bedside 49
Expression of classical NF-kappa B pathway molecules in peripheral t-cell lymphoma not otherwise specified. 49
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 49
Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma 29
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified 22
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma 7
Totale 2677
Categoria #
all - tutte 3384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201874 0000 21 01 40651
2018/2019255 334125 838 176 32271252
2019/2020867 14123759 6976 103118 96604669
2020/2021473 9035314 811 614 58139212
2021/2022707 36463243 6936 1029 32101165108
2022/2023291 104131488 00 00 0000
Totale 2677